Similar articles for PMID: 19827270

Year	Number of Results
1957	1
1961	1
1976	1
1982	1
1983	1
1985	1
1987	1
1989	1
1998	1
2000	1
2001	1
2003	1
2004	2
2005	1
2006	4
2007	5
2008	12
2009	36
2010	2
2012	1
2013	2
2014	4
2015	4
2016	1
2017	1
2018	2
2021	1
2022	2

1

Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.

Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H. Shigama K, et al. J Exp Ther Oncol. 2009;8(1):43-51. J Exp Ther Oncol. 2009. PMID: 19827270

2

The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.

Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI. Hirose A, et al. Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. doi: 10.1016/j.taap.2007.03.031. Epub 2007 Apr 20. Toxicol Appl Pharmacol. 2007. PMID: 17555784

3

Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.

Nogusa S, Gerbino J, Ritz BW. Nogusa S, et al. Nutr Res. 2009 Feb;29(2):139-43. doi: 10.1016/j.nutres.2009.01.005. Nutr Res. 2009. PMID: 19285605

4

Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents.

Mach CM, Fugii H, Wakame K, Smith J. Mach CM, et al. J Soc Integr Oncol. 2008 Summer;6(3):105-9. J Soc Integr Oncol. 2008. PMID: 19087767

5

Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice.

Lee CK, Son SH, Park KK, Park JH, Lim SS, Kim SH, Chung WY. Lee CK, et al. Basic Clin Pharmacol Toxicol. 2008 Jul;103(1):48-54. doi: 10.1111/j.1742-7843.2008.00238.x. Epub 2008 Jul 1. Basic Clin Pharmacol Toxicol. 2008. PMID: 18484961 Free article.

6

Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice.

Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S. Nakashima-Kamimura N, et al. Cancer Chemother Pharmacol. 2009 Sep;64(4):753-61. doi: 10.1007/s00280-008-0924-2. Epub 2009 Jan 16. Cancer Chemother Pharmacol. 2009. PMID: 19148645

7

Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection.

Aviles H, O'Donnell P, Orshal J, Fujii H, Sun B, Sonnenfeld G. Aviles H, et al. Am J Surg. 2008 Apr;195(4):537-45. doi: 10.1016/j.amjsurg.2007.05.045. Am J Surg. 2008. PMID: 18304499

8

Amelioration by active hexose correlated compound of endocrine disturbances induced by oxidative stress in the rat.

Ye SF, Wakame K, Ichimura K, Matsuzaki S. Ye SF, et al. Endocr Regul. 2004 Mar;38(1):7-13. Endocr Regul. 2004. PMID: 15147233

9

Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in the rat.

Burikhanov RB, Wakame K, Igarashi Y, Wang S, Matsuzaki S. Burikhanov RB, et al. Endocr Regul. 2000 Dec;34(4):181-8. Endocr Regul. 2000. PMID: 11137978

10

The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.

Tseng CL, Su WY, Yen KC, Yang KC, Lin FH. Tseng CL, et al. Biomaterials. 2009 Jul;30(20):3476-85. doi: 10.1016/j.biomaterials.2009.03.010. Epub 2009 Apr 5. Biomaterials. 2009. PMID: 19345990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed